Individuals with inflammatory rheumatic disease require special consideration with regard to
coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome …

The COVID-19 pandemic has already caused over 400 000 infections and led to over 17
000 deaths worldwide, dramatically disrupted daily life, and is placing extreme demands on …

The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …

Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …

As of January, 2021, nearly 2-million deaths worldwide have been attributed to COVID-19,
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Much …

Background In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic
diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 …

Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

The global health emergency generated by the SARS-CoV-2 outbreak has complicated the
management of patients with comorbidities, which together with old age seem to be the …